These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 21163349)
21. Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules. Miller JH; Das V Curr Pharm Des; 2020; 26(35):4362-4372. PubMed ID: 32564745 [TBL] [Abstract][Full Text] [Related]
23. Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs. Brunden KR; Lee VM; Smith AB; Trojanowski JQ; Ballatore C Neurobiol Dis; 2017 Sep; 105():328-335. PubMed ID: 28012891 [TBL] [Abstract][Full Text] [Related]
24. Non-taxoid site microtubule-stabilizing drugs work independently of tau overexpression in mouse N2a neuroblastoma cells. Das V; Miller JH Brain Res; 2012 Dec; 1489():121-32. PubMed ID: 23085090 [TBL] [Abstract][Full Text] [Related]
25. Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel. Shemesh OA; Spira ME Neurobiol Dis; 2011 Jul; 43(1):163-75. PubMed ID: 21406229 [TBL] [Abstract][Full Text] [Related]
26. Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons. Jang EH; Sim A; Im SK; Hur EM Neural Plast; 2016; 2016():5056418. PubMed ID: 27872763 [TBL] [Abstract][Full Text] [Related]
27. Taxane- and epothilone-based chemotherapy: from molecule cargo cytoskeletal logistics to management of castration-resistant prostate carcinoma. Alberti C Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1658-64. PubMed ID: 23832735 [TBL] [Abstract][Full Text] [Related]
28. Epothilones and new analogues of the microtubule modulators in taxane-resistant disease. Harrison M; Swanton C Expert Opin Investig Drugs; 2008 Apr; 17(4):523-46. PubMed ID: 18363517 [TBL] [Abstract][Full Text] [Related]
29. A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. Matsuoka Y; Jouroukhin Y; Gray AJ; Ma L; Hirata-Fukae C; Li HF; Feng L; Lecanu L; Walker BR; Planel E; Arancio O; Gozes I; Aisen PS J Pharmacol Exp Ther; 2008 Apr; 325(1):146-53. PubMed ID: 18199809 [TBL] [Abstract][Full Text] [Related]
30. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils. Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461 [TBL] [Abstract][Full Text] [Related]
31. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in Mao CX; Wen X; Jin S; Zhang YQ Dis Model Mech; 2017 Oct; 10(10):1245-1252. PubMed ID: 28819043 [TBL] [Abstract][Full Text] [Related]
32. Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation. Ballatore C; Brunden KR; Piscitelli F; James MJ; Crowe A; Yao Y; Hyde E; Trojanowski JQ; Lee VM; Smith AB J Med Chem; 2010 May; 53(9):3739-47. PubMed ID: 20392114 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Structure-Activity Relationship of Microtubule-Targeting 1,2,4-Triazolo[1,5- Oukoloff K; Nzou G; Varricchio C; Lucero B; Alle T; Kovalevich J; Monti L; Cornec AS; Yao Y; James MJ; Trojanowski JQ; Lee VM; Smith AB; Brancale A; Brunden KR; Ballatore C J Med Chem; 2021 Jan; 64(2):1073-1102. PubMed ID: 33411523 [TBL] [Abstract][Full Text] [Related]
34. Correction of microtubule defects within Aβ plaque-associated dystrophic axons results in lowered Aβ release and plaque deposition. Yao Y; Nzou G; Alle T; Tsering W; Maimaiti S; Trojanowski JQ; Lee VM; Ballatore C; Brunden KR Alzheimers Dement; 2020 Oct; 16(10):1345-1357. PubMed ID: 32918367 [TBL] [Abstract][Full Text] [Related]
35. Systemic epothilone D improves hindlimb function after spinal cord contusion injury in rats. Sandner B; Puttagunta R; Motsch M; Bradke F; Ruschel J; Blesch A; Weidner N Exp Neurol; 2018 Aug; 306():250-259. PubMed ID: 29408734 [TBL] [Abstract][Full Text] [Related]
36. Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors. Rice A; Michaelis ML; Georg G; Liu Y; Turunen B; Audus KL J Mol Neurosci; 2003; 20(3):339-43. PubMed ID: 14501017 [TBL] [Abstract][Full Text] [Related]
37. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy. Ivashko-Pachima Y; Gozes I Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943 [TBL] [Abstract][Full Text] [Related]
38. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers. Killinger BA; Moszczynska A J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic effect against human xenograft tumors in nude mice by the third generation microtubule stabilizing epothilones. Chou TC; Zhang X; Zhong ZY; Li Y; Feng L; Eng S; Myles DR; Johnson R; Wu N; Yin YI; Wilson RM; Danishefsky SJ Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13157-62. PubMed ID: 18755900 [TBL] [Abstract][Full Text] [Related]
40. Effect of taxoid and nontaxoid site microtubule-stabilizing agents on axonal transport of mitochondria in untransfected and ECFP-htau40-transfected rat cortical neurons in culture. Das V; Sim DA; Miller JH J Neurosci Res; 2014 Sep; 92(9):1155-66. PubMed ID: 24788108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]